Company news
Sinocelltech Group Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Convening the Q3 2024 Performance Briefing
November 6, 2024
Report for Q3 2024
October 28, 2024
Announcement on the Company's Voluntary Disclosure of Approval Notice for the Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine SCTV02 by the Company's Holding Subsidiary
October 22, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
September 6, 2024
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04C
September 5, 2024
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCT520FF
September 2, 2024
Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB41
August 23, 2024
Announcement on the Resignation and By-election of the Company's Directors and the Adjustment of Audit Committee Members
August 21, 2024